http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#Head http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#assertion http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#provenance http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#pubInfo http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#assertion https://uts.nlm.nih.gov/uts/umls/concept/C0040732 http://wordnet-rdf.princeton.edu/lemma/compare https://uts.nlm.nih.gov/uts/umls/concept/C0011777 http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#provenance http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:34:29.176540 http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 2 http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#version http://www.w3.org/ns/prov#value 2 http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label with lenalidomide and dexamethasone alone ( Rd ) http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 21 http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label compared http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION http://www.w3.org/2000/01/rdf-schema#label [221] http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label lenalidomide and dexamethasone ( DRd ) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 91 http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:6bnj8pcp&rows=50 6bnj8pcp http://www.w3.org/2000/01/rdf-schema#SENTENCE http://www.w3.org/2000/01/rdf-schema#label PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide and dexamethasone alone (Rd). http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:6bnj8pcp-TRIPLE-ABSTRACT-5 6bnj8pcp-TRIPLE-ABSTRACT-5 https://uts.nlm.nih.gov/uts/umls/concept/C0011777 http://www.w3.org/2000/01/rdf-schema#label dexamethasone https://uts.nlm.nih.gov/uts/umls/concept/C0040732 http://www.w3.org/2000/01/rdf-schema#label transplant http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#pubInfo http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#assertion http://www.w3.org/ns/prov#wasDerivedFrom https://doi.org/10.1200/jco.20.01849 http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#sig http://purl.org/nanopub/x/hasSignature Q9WESfeLrrahGhAFFhojbV3le3hfgppA0fQpOfX4Xu2TBE2Z/d1lbhetExTpRISPgtNgbo/3+6VrTCItxelEVpAAUWgPPx4JAC2BqXiep7Wkun3K4zYBG3V0//YJMzLkUy8s30sRGQilkhv0vzwX06yPJUIu1qu7YmodrpQIPCk= http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:34:29.176540 http://purl.org/np/RAGRUUkNtpNovi-kOlwUio3lplH5K9i1ajXon6RBpPT_A http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470